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Abstract: Four days of high-fat diet (HFD) feeding are sufficient to induce glucose intolerance and hep-
atic steatosis in mice. While prolonged HFD-induced metabolic complications are partly mediated by
increased food intake during the light (inactive) phase, such a link has not yet been established in short-
term HFD-fed mice. Herein, we hypothesized that a short bout of HFD desynchronizes feeding behavior,
thereby contributing to glucose intolerance and hepatic steatosis. To this end, 12-wk-old C57BL/6J lit-
termates were fed a HFD for 4 days either ad libitum or intermittently. Intermittent-fed mice were fasted
for 8 h during their inactive phase. Initiation of HFD led to an immediate increase in food intake already
during the first light phase. Moreover, glucose tolerance was significantly impaired in ad libitum- but not
in intermittent HFD-fed mice, indicating that desynchronized feeding behavior contributes to short-term
HFD-induced glucose intolerance. Of note, overall food intake was similar between the groups, as was
body weight. However, intermittent HFD-fed mice revealed higher fat depot weights. Phosphorylation of
hormone sensitivity lipase and free fatty acid release from isolated adipocytes were significantly elevated,
suggesting increased lipolysis in intermittent HFD-fed mice. Moreover, hepatic mRNA expression of li-
pogenetic enzymes and liver triglyceride levels were significantly increased in intermittent HFD-fed mice.
Importantly, food deprivation decreased respiratory exchange ratio promptly in intermittent- but not
in ad libitum HFD-fed mice. In conclusion, retaining a normal feeding pattern prevented HFD-induced
impairment of metabolic flexibility in short-term HFD-fed mice.
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Four days of high-fat diet (HFD) feeding are sufficient to induce glucose intolerance 2 
and hepatic steatosis in mice. While prolonged HFD-induced metabolic complications are 3 
partly mediated by increased food intake during the light (inactive) phase, such a link has 4 
not yet been established in short-term HFD-fed mice. Herein, we hypothesized that a short 5 
bout of HFD desynchronizes feeding behavior thereby contributing to glucose intolerance 6 
and hepatic steatosis. To this end, 12 week-old C57BL/6J littermates were fed a HFD for 7 
four days either ad libitum or intermittently. Intermittent fed mice were fasted for eight 8 
hours during their inactive phase. Initiation of HFD led to an immediate increase in food 9 
intake already during the first light phase. Moreover, glucose tolerance was significantly 10 
impaired in ad libitum but not in intermittent HFD-fed mice, indicating that desynchronized 11 
feeding behavior contributes to short-term HFD-induced glucose intolerance. Of note, 12 
overall food intake was similar between the groups, as was body weight. However, 13 
intermittent HFD-fed mice revealed higher fat depot weights. Phosphorylation of hormone 14 
sensitivity lipase (HSL) as well as free fatty acid (FFA) release from isolated adipocytes 15 
were significantly elevated suggesting increased lipolysis in intermittent HFD-fed mice. 16 
Moreover, hepatic mRNA expression of lipogenetic enzymes as well liver triglyceride 17 
levels were significantly increased in intermitted HFD-fed mice. Importantly, food 18 
deprivation decreased respiratory exchange ratio promptly in intermittent but not in ad 19 
libitum HFD-fed mice. In conclusion, retaining a normal feeding pattern prevented HFD-20 




More than 400 million people worldwide suffered from type 2 diabetes in 2015, with 23 
a further increase predicted. Its high prevalence makes it one of the greatest health 24 
challenges nowadays (50). In parallel, the worldwide increasing prevalence of obesity, 25 
which is the strongest risk factor for insulin resistance and type 2 diabetes, is alarming  26 
(25, 59). Therefore, understanding the underlying mechanisms linking obesity to insulin 27 
resistance is of utmost interest.  28 
Chronic and short-term high-fat diet (HFD) negatively affect metabolic health (40, 29 
53). Besides food composition and caloric content, timing of food intake plays a pivotal 30 
role. Feeding rodents a HFD ad libitum disrupts their diurnal feeding rhythm (23, 32). 31 
Under normal chow conditions, mice consume the vast majority of their food during the 32 
active/dark phase (14). Of note, a circadian misalignment of food intake and sleep-wake 33 
or activity-inactivity rhythm is closely linked to metabolic disease in rodents and humans, 34 
and is associated with weight gain, impaired glucose tolerance and/or disturbed lipid 35 
metabolism (1, 9, 10, 29, 46). Interestingly, avoiding feeding desynchronization by 36 
restricting food access of HFD-fed mice to their active/dark phase prevented HFD-37 
associated adverse metabolic effects (6, 23, 58). Of importance, in some studies the 38 
positive impact of prolonged fasting on metabolism in HFD-fed mice, as observed for time-39 
restricted feeding or intermittent fasting regimens, could not be attributed to differences in 40 
caloric intake, because cumulative food intake was similar between intermittent fasted and 41 
ad libitum-fed animals (23, 38). However, such positive impact of prolonged fasting on 42 
metabolism has only been reported in mice after several weeks of HFD-feeding. 43 
We and others have previously shown that glucose tolerance and lipid metabolism 44 
were impaired in mice already after a short bout of HFD (8, 19, 22, 27, 34, 53). In the 45 
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current study, we aimed to investigate whether a short bout of HFD desynchronizes 46 
feeding behavior thereby contributing to glucose intolerance as well as hepatic steatosis 47 
and whether re-establishing a diurnal feeding pattern by limiting food access to the 48 
active/dark phase prevents metabolic impairments four days HFD-fed mice. 49 
 50 
 51 
Material and Methods 52 
 53 
Animals 54 
12 weeks old male C57BL/6J wildtype littermate mice were assigned to either an 55 
ad libitum or an intermittent HFD-feeding regiment for four days (HFD; 59 kcal% fat 56 
(coconut oil, mainly saturated fatty acids), 26 kcal% carbohydrates (13% sucrose), 15 57 
kcal% protein; #E15772-347, ssniff-Spezialdiäten GmbH, Soest, Germany). In the 58 
intermittent HFD-feeding group, food was removed from the cage for eight hours during 59 
the inactive/light phase, whereas ad libitum fed mice had free access to food 24 hours a 60 
day. Mice were allocated to groups based on body weight (similar mean +/- SD in starting 61 
body weight between the groups). 62 
Mice were housed in a pathogen free animal facility on a 12 h dark/light cycle (light 63 
on from 7 am to 7 pm) at room temperature (21°C). After weaning, mice were ad libitum 64 
fed a regular chow diet (12 kcal% fat (soybean and sunflower oil, mainly unsaturated fatty 65 
acids), 57 kcal% carbohydrates, 31 kcal% protein; #3436, ProvimiKliba, Kaiseraugst, 66 
Switzerland) until the age of 12 weeks. The same diet was used for chow-fed mice in 67 
experiments. All animal studies were conformed to the Swiss animal protection laws and 68 




Intraperitoneal glucose tolerance tests 71 
Intraperitoneal glucose tolerance test (ipGTT) was performed in 12 week-old chow-72 
fed mice after five hours of fasting. The test was repeated after one week recovery period 73 
followed by the respective four-day feeding-regimen. Glucose (2g/kg body weight) was 74 
injected intraperitoneally (ip) and blood glucose concentration was measured from blood 75 
received after tail vessel incision after 15, 30, 45, 60, 90 and 120 min by using a 76 
glucometer (Accu-Check Aviva, Roche Diagnostics) (33). 77 
 78 
Metabolic cage analysis 79 
Food intake and respiratory exchange ratio (RER) were assessed in 24-hour 80 
single-housed mice in the PhenoMaster system (TSE Systems, Bad Homburg, Germany). 81 
Mice were group-housed before placement in the metabolic cages. One week before 82 
starting HFD, mice were single-housed in metabolic cages for two days to adapt and avoid 83 
stress during analysis. For data presented in Figure 1, HFD was started immediately after 84 
placing mice in metabolic cages. For data presented in Figs. 2 and 5, mice were group-85 
housed for the first 3 days of the feeding regimen before placing them into metabolic 86 
cages. Three data points/hour were recorded over a 24 hour period for O2 consumption 87 
and CO2 production. RER was calculated using the manufacturer's software. 88 
 89 
Determination of circulating parameters 90 
EDTA (5 mmol/L) was added to blood collected from the portal vein or heart right 91 
after scarification of mice fasted for 5 hours. Blood was immediately centrifuged (4°C, 92 
8000 rpm, 10 min) and obtained plasma was stored at -80°C until further analysis.  93 
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Circulating free fatty acid (FFA) concentrations were determined as described using an 94 
enzymatic assay (11) (Wako Chemicals GmbH, Neuss, Germany). Insulin was 95 
determined as previously described (33). 96 
 97 
Weighing and tissue sampling 98 
Ad libitum and intermittent fed mice were weighed daily at the beginning of the 99 
fasting period of the intermittent fed mice (at 9 am) and again at the end of the 8-hour 100 
fasting period (at 5 pm) using a precision balance (PCP-2000-1, Kern + Sohn, Balingen, 101 
Germany). Food was weighed at the same two time points. After the four-day feeding 102 
regimen, all mice were fasted at day five from 9.00 am (time of food withdrawal in the 103 
intermittent group) to 2.00 pm. Thereafter, mice were euthanized using CO2 and tissues 104 
was collected.  105 
 106 
Lipolysis assay 107 
Adipocytes were isolated as previously described (45). 400 µl of packed isolated 108 
adipocytes were incubated in 600 µl Krebs Ringer HEPES buffer (KRH) containing 1% 109 
(w/v) fatty acid-free BSA (Sigma, Buchs, Switzerland) in the absence or presence of 1μM 110 
isoproterenol (Sigma) for one hour. FFA levels in the incubation medium were measured 111 
using an enzymatic assay (Wako Chemicals GmbH). Number of incubated cells was 112 
determined with a hemocytometer under the light microscope.  113 
 114 
Lipid metabolite measurement in liver tissue 115 
1 ml of 50 mM Potassium phosphate buffer was used to lyse 30 mg of frozen liver 116 
tissue. Thereafter, lipids were extracted using the protocol of Bligh and Dyer (2) with a 117 
7 
 
chloroform/methanol solvent (1:2 v/v) containing N-Heptadecanoyl-D-Spingosine and 118 
1,2.Dilaurin (Larodan, Solna, Sweden) as internal standards in a 1 μM final concentration. 119 
Lipids were air-dried and redissolved in 200 μl methanol and diluted 5 times in 120 
methanol/water (4:1 v/v) containing 10 mM ammonium acetate. Thereafter, lipids were 121 
referred to liquid chromatography-mass spectrometry (LC-MS) and analysis was 122 
conducted applying the Data Dependent Acquisition (DDA) method. Obtained data were 123 
processed and compounds were identified using a data analysis software (ProgenesisQI). 124 
Thereafter, identified metabolites were clustered into lipid classes and subclasses (using 125 
LIPID MAPS®). Markedly changed metabolites were included into the analysis (≥50% 126 
difference in signal intensity between the two groups) and individual thresholds for signal 127 
intensity was set for each lipid class to identify the most abundant metabolites within the 128 
respective class. 129 
 130 
Histology 131 
Epididymal adipose tissue was fixed in 4% buffered formalin and thereafter 132 
paraffin-embedded. Embedded tissue was cut (4 µm) and sections were stained with 133 
hematoxylin and eosin. Adipocyte perimeter was analyzed in pictures from two different 134 
sections per mouse using Image J software (National Institutes of Health, Bethesda, MD, 135 
USA) (33). 136 
 137 
Triglyceride determination 138 
Triglycerides of about 100 mg liver tissue were extracted according to the method 139 
of Bligh and Dyer (2). Extracted triglyceride concentrations were determined using a 140 




RNA extraction and quantitative reverse transcription-PCR 143 
RNA was extracted with a commercially available kit (NucleoSpin® RNA Set for 144 
NucleoZOL, Macherey-Nagel, Düren, Germany) and reverse transcribed as described 145 
before (56). To determine relative gene expression levels, cDNA was amplified using 146 
TaqMan assay (Applied Biosystems, Foster City, California, USA) and thereafter 147 
normalized to 18s RNA using the 2-∆∆CT method (36). The following primers were used: 148 
Acox1 (Mm00443579_m1), Cpt1 (Mm00550438_m1), Cd36 (Mm00432403_m1), Acc1 149 
(Mm01304257_m1), Fas (Mm00662319_m1), Acad1 (Mm00599660_m1), Pparα 150 
(Mm00627559_m1), Il6 (Mm00446190_m1), Il10 (Mm00439614_m1), Tnfα 151 
(Mm00443258_m1) (Applied Biosystems). 152 
 153 
Western blotting 154 
Tissue samples were lyzed and protein concentrations were determined as 155 
previously described (26). Proteins were separated by sodium dodecyl sulfate 156 
polyacrylamide gel electrophoresis (SDS-PAGE) and subsequently, transferred onto 157 
nitrocellulose membranes (0.2μm, Bio-Rad, Hercules, California, USA). Membranes were 158 
incubated with primary antibodies overnight at 4°C. The following primary antibodies were 159 
used: anti-Actin (MAB1501) (Millipore, Billerica, Massachusetts, USA), anti-phospho-ERK 160 
1/2 (Thr202/Tyr204, #9101), anti-ERK 1/2, (#9102),  anti-phospho-HSL (Ser660, #4216) 161 
and anti-HSL (#4107S) (Cell Signaling Technology, Danvers, Massachusetts, USA), anti-162 
PPARγ (H-100) (Santa Cruz Biotechnology, Dallas, Texas, USA).  163 
 164 
Data analysis 165 
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Data were analyzed by unpaired, two-tailed Student’s t-test or, for comparison of 166 
ipGTTs before and after feeding the respective regimen, by paired, two-tailed Student’s t-167 
test. For multiple group comparison, two-way analysis of variance (ANOVA) followed by 168 
Bonferroni post-hoc test was applied. Data are presented as mean ± SEM. p values < 169 
0.05 were considered significant. Power calculation analysis was not performed. Sample 170 




Ad libitum HFD feeding desynchronizes food intake immediately 175 
To investigate whether a short bout of HFD desynchronizes feeding behavior, food 176 
intake in 12 weeks old male C57BL/6J wildtype was analyzed in metabolic cages. 177 
Immediately before starting analysis, littermates were either assigned to a HFD regimen 178 
or were consecutively fed a chow diet. Intake of the respective diet was monitored over 179 
24 hours. Of note, the diet-switch from chow to HFD was conducted during the 180 
inactive/light phase. Interestingly, immediately after exposure to HFD, mice began to feed 181 
(Fig. 1A). In contrast, littermates remaining under chow diet showed a normal feeding 182 
pattern with a clear preference to food intake during the active/dark phase. Consequently, 183 
food intake during the inactive/light phase was significantly lower in chow but not in HFD-184 
fed mice (Fig. 1B). Similarly, caloric intake significantly increased in the active/dark when 185 
compared to the inactive/light phase only in chow-fed mice (for chow-fed: inactive/light 186 
1.4±0.6 kcal vs. active/dark 7.1±1.8 kcal; p<0.01) (for HFD-fed: inactive/light 5.2±0.5 kcal 187 
vs. active/dark 6.5±0.8 kcal; p>0.9). HFD-fed mice consumed almost half of their daily 188 
food intake during the light phase (Fig. 1C). Of note, the distinct feeding patterns were 189 
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also reflected in the respiratory exchange ratio (RER) (Figs. 1D and 1E). As expected, 190 
chow-fed mice showed reduced RER during their inactive/light phase, when they abstain 191 
from food and therefore switch to lipid oxidation. In contrast, HFD-fed mice, that consumed 192 
constantly food, did not show fluctuations in the RER during the course of the day. Taken 193 
together, HFD desynchronizes food intake immediately. 194 
 195 
Four days of intermittent HFD-feeding imposes a physiological pattern of food intake and 196 
fuel utilization  197 
As previously reported by us and other groups, four days of ad libitum HFD-feeding 198 
are sufficient to induce hepatic steatosis and impair glucose tolerance (22, 27, 34, 53). 199 
Given the fact that HFD feeding immediately affects food intake (Fig. 1A to 1C), we 200 
hypothesized that desynchronization in food intake contributes to the observed metabolic 201 
alterations in four-day HFD-fed mice. To investigate such hypothesis we assigned 12-202 
week old mice either to a four-day ad libitum HFD-feeding protocol or to a four-day 203 
intermittent HFD-feeding protocol (Fig. 2A). Ad libitum fed mice had constant access to 204 
food, whereas food access in intermittent fed animals was limited with food deprivation for 205 
eight hours during the inactive/light phase. Intermittent fed mice showed a similar four-206 
day cumulative food intake as ad libitum fed littermates (Fig. 2B). Similarly, body weight 207 
was not different between the two groups (Fig 2C). However, intermittent fed mice lost 208 
more weight during the inactive/light phase and gained more weight during the active/dark 209 
phase (Fig. 2D). Daily food intake as shown for the fourth day was similar between the 210 
two groups (Figs. 2E and 2F). Whereas RER was similar between the inactive/light and 211 
active/dark phase in ad libitum fed mice, RER significantly increased during the 212 
active/dark phase in intermittent fed mice (Figs. 2G and 2H). O2 consumption did not 213 
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significantly differ between the groups (Fig. 2I), indicating similar energy expenditure. In 214 
addition, 24-hour locomotor activity was not different between the groups (ad libitum 215 
2223±37 m vs. intermittent 2281±528 m; p=0.9). Collectively, intermittent feeding blunts 216 
HFD-induced impairment of metabolic flexibility. 217 
 218 
Intermittent HFD-feeding enhances fat accumulation and fasting-induced lipolysis in white 219 
adipose tissue   220 
Adipose tissue morphology was assessed next. As depicted in Fig. 3A, weight of 221 
epididymal (eWAT), inguinal (iWAT) and mesenteric white adipose tissue (mesWAT) was 222 
significantly higher in intermittent HFD-fed compared to ad libitum HFD-fed mice after four 223 
days of HFD. Analysis of histological sections revealed increased adipocyte size in 224 
intermittent fed mice (Fig. 3B). In order to explore lipolytic activity, phosophorylation of 225 
extracellular-signal regulated kinase (ERK) and hormone-sensitive lipase (HSL) was 226 
determined in iWAT after five hours of fasting. Phosphorylation of both ERK and HSL were 227 
significantly elevated in intermittent compared to ad libitum fed mice (Figs. 3C and 3D). In 228 
addition, basal FFA release from isolated epididymal as well as inguinal adipocytes was 229 
significantly increased in intermittent compared to ad libitum HFD-fed mice (Figs. 3E and 230 
3F). Of note, isoproterenol-stimulated FFA release was not different between the groups 231 
(for epididymal adipocytes: ad libitum 2.2±0.3 µmol/106 cells vs. intermittent 2.5±0.5 232 
µmol/106 cells; p=0.6) (for inguinal adipocytes: ad libitum 3.5±0.4 µmol/106 cells vs. 233 
intermittent 3.3±1.3 µmol/106 cells; p=0.9). Furthermore, the finding of increased basal 234 
FFA release from adipocytes was accompanied by a ~40% increase of portal free fatty 235 
acids (FFA) levels in intermittent fed mice (p=0.12) (Fig. 3G). Taken together, intermittent 236 
HFD-feeding enhances adipogenesis and lipolysis. 237 
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  238 
Intermittent HFD promotes hepatic lipid accumulation, β-oxidation and lipogenesis 239 
Liver morphology was determined thereafter. As depicted in Fig. 4A, liver weight 240 
did not differ between ad libitum and intermittent fed littermates after four days of HFD. In 241 
line with enhanced lipolysis in white adipose tissue, peroxisome proliferator-activated 242 
receptor γ (PPARγ) protein levels were increased in the liver of intermittent fed mice (Fig. 243 
4B). The latter can be activated upon fatty acid binding and induces a lipogenic program 244 
(16). Accordingly, mRNA expression of enzymes involved in lipogenesis was increased 245 
(Fig. 4C). The latter was accompanied by a threefold increase in hepatic triglycerides 246 
levels (Fig. 4D). Moreover, there was a significant increase in various triglyceride and 247 
diacylglycerol fractions in the liver of intermittent compared to ad libitum fed mice (Figs. 248 
4E and 4F). 249 
PPARα is the major inducer of β-oxidation and similar to PPARγ, it is upregulated 250 
in response to fasting (30). As depicted in Fig. 4G, mRNA expression of PPARα as well 251 
as of other enzymes involved in β-oxidation was increased in intermittent compared to ad 252 
libitum fed mice after four days of HFD. In accordance with an upregulation of β-oxidation 253 
enzymes, various fatty acyl carnitine fractions were reduced in intermittent fed mice (Fig. 254 
4H). Of note, mRNA expression of the pro-inflammatory cytokines Tnfα and Il6 were 255 
reduced in intermittent compared to ad libitum fed mice (Fig. 4I) indicating reduced hepatic 256 
inflammation. 257 
 258 
Four days of intermittent HFD-feeding prevents impairment of HFD-induced glucose 259 
tolerance and metabolic flexibility 260 
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We next wanted to assess the impact of intermittent HFD-feeding on glucose 261 
metabolism. As depicted in Fig. 5A and 5B, glucose tolerance was significantly impaired 262 
after four days of ad libitum HFD feeding. In contrast, four days of intermittent HFD did 263 
not impair area under the curve (AUC) of a glucose tolerance test (Fig. 5B). When 264 
comparing ad libitum vs. intermittent HFD-fed mice, there was no significant difference 265 
between the two groups (ad libitum 2019±153 mmol/l*min vs. intermittent 1807 ± 110 266 
mmol/l*min; p=0.28). Of note, blood glucose disposal curve in intermittent fed mice 267 
showed a special pattern with a quick decline 15 minutes after glucose injection and a 268 
plateau between 30 and 60 minutes (Fig. 5A).  Moreover, there was a trend to increased 269 
circulating insulin levels in intermittent HFD-fed mice after 5-hours of fasting (ad libitum 270 
0.94±0.12 ng/ml vs. intermittent 1.22±0.10 ng/ml; p=0.10). After four days of HFD-feeding 271 
we assessed RER after food deprivation. Importantly, intermittent fed mice depicted a 272 
rapid decline in RER immediately after initiation of starvation whereas RER of ad libitum 273 
fed mice remained more or less unchanged in the first 60 minutes after food withdrawal 274 
(Fig. 5C). Accordingly, mean RER in the first hour after food deprivation was significantly 275 
lower in intermittent compared to ad libitum fed mice (Fig. 5D). In contrast, mean O2 276 
consumption did not differ between the groups (ad libitum 4109±206 ml/h*kg vs. 277 
intermittent 3692±240 ml/h*kg; p=0.25). These results suggest maintained metabolic 278 
flexibility in intermittent but not ad libitum HFD-fed mice.   279 
 280 
Discussion 281 
The current study suggests that a short bout of HFD desynchronizes feeding 282 
pattern as characterized by increased food intake during the inactive/light phase, thereby 283 
contributing to glucose intolerance, hepatic steatosis and metabolic inflexibility. Such 284 
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notion is based on the following findings: i. a short bout of HFD desynchronizes feeding 285 
behavior by increasing food consumption during the inactive/light phase; ii. a short bout 286 
of ad libitum HFD impaired glucose tolerance and deprivation-induced decline in RER, 287 
which was both prevented in intermittent HFD-fed mice.  288 
Previous studies have shown that limiting food access to the active/dark phase has 289 
positive effects on metabolism in rodents and humans (23, 42, 49, 54). Even the time slot 290 
during the active/dark phase to which food access is limited to may play an important role 291 
in maintaining metabolic health. For instance, adults that skip breakfast are more prone 292 
to develop obesity (37). Moreover, food supply in a “breakfast-regimen” with limited food 293 
to the beginning of the active/dark phase seems to be beneficial in rodents and in humans 294 
(3, 49). In the current study, intermittent-fed mice consumed the vast majority of their daily 295 
food during the early active/dark phase, whereas ad libitum fed mice did not exhibit such 296 
an increase in food intake in the early active/dark phase. Eating behavior in alignment 297 
with the circadian clock might be responsible for the observed beneficial outcome in these 298 
time-restricted feeding regimens. Various key-enzymes involved in metabolic processes 299 
show very specific fluctuations in activity and expression profile during the course of the 300 
day to optimally meet the body’s energetic needs (43). In this context, it has been shown 301 
that individuals which a misalignment of eating behavior and sleep/wake-cycle, such as 302 
humans suffering from night eating syndrome or shift-workers, had an increased risk to 303 
develop metabolic disorders (10, 29, 48). Herein, intermittent HFD feeding, which 304 
simulates the feeding pattern of chow fed mice, prevented HFD-induce impairment of 305 
glucose tolerance as well as food-deprivation induced rapid decline in RER even though 306 
the total amount of food intake was not different. The latter was due to a compensatory 307 
increase in food intake during the active/dark phase as was previously reported in mice 308 
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that had time restricted access to food (23, 38, 58). Such enhanced food intake during the 309 
active/dark phase may explain the observed increase in WAT depot weight, which serves 310 
as preventive energy storage.   311 
Fasting-induced increase in FFA levels serve as energy source (7, 15) and, 312 
importantly, shifts fuel utilization from glucose to fat oxidation (13, 55). Herein, intermittent 313 
HFD-fed mice exhibited increased phosphorylation of ERK 1/2 and HSL in WAT as well 314 
as elevated portal FFA levels after five hours of fasting compatible with activated lipolysis 315 
(18, 24). Such finding suggests higher FFA flux to the liver in intermittent fed mice, which 316 
may be responsible for the observed increase in hepatic triglyceride accumulation. In 317 
obese humans, the main source of hepatic triglycerides in the fasted state are adipose-318 
derived FFAs (12). Moreover, lipid infusion in rats has been shown to promote hepatic 319 
triglyceride accumulation, indicating that hepatic triglyceride synthesis is dependent on 320 
increased FFA flux to the liver (51). In this regard, 24 hours of fasting induced hepatic 321 
triglyceride accumulation in C57/BL/6J mice (21). Despite the observed hepatic 322 
diacylglycerol and triglyceride accumulation, glucose tolerance was slightly, albeit not 323 
significantly, improved intermittent compared to ad libitum HFD-fed mice. What is the 324 
potential benefit of increased hepatic triglyceride (and diacylglycerol) storage?  Hepatic 325 
triglycerides serve as integral part of very low density lipoproteins (VLDL) and are in this 326 
form secreted into the circulation in a controlled manner to meet the energetic needs of 327 
peripheral tissues (21, 41). Thus, the liver might serve as lipid buffering system to ensure 328 
a perpetual fuel supply to peripheral organs in times of starvation. Such function is 329 
maintained in intermittent HFD-fed mice, but lost in ad libitum HFD-fed mice. In 330 
accordance, time-restricted-fed human subjects were reported to have increased fasting-331 
induced circulating triglycerides levels (49). Moreover, increased triglyceride accumulation 332 
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in intermittent HFD-fed mice may be lost over time since previous studies demonstrated 333 
diminished hepatic triglyceride in mice that were interval-fasted for a much longer 334 
timeframe (5, 6, 23, 54). 335 
In line with enhanced lipolysis and, concomitantly, higher circulating FFA flux, 336 
hepatic protein levels of the lipid-responsive PPARγ1 were significantly higher in 337 
intermittent HFD-fed mice. PPAR γ1 is a ligand-stimulated transcription factor that can be 338 
activated (among others) upon fatty acid-binding resulting in the induction of a lipogenic 339 
transcriptional program (17, 47). Of note, mice with a liver-specific loss of PPARγ revealed 340 
reduced hepatic triglyceride accumulation, but exhibited impaired glucose tolerance (16, 341 
39). Opposingly, PPARα knockout-mice with liver-specific PPARy1 overexpression 342 
depicted enhanced hepatic steatosis (57). Accordingly, hepatic upregulation of PPARy1 343 
in intermittent HFD-fed mice may be responsible for the observed induction of lipogenic 344 
target genes such as Fas and Acc1 promoting triglyceride accumulation. In addition, 345 
upregulation of PPARy1 may explain reduced expression of pro-inflammatory cytokines 346 
as observed in intermittent fed mice (28). 347 
In addition, PPARα, the master regulator of β-oxidation, is upregulated in response 348 
to fasting. In contrast to PPARγ, PPARα expression in the liver is not activated by adipose-349 
derived FFA, but shows a strong circadian induction during the fasted/light phase (30, 31, 350 
35). In accordance with such notion, PPARα mRNA expression was increased in 351 
intermittent HFD-fed mice. In agreement with PPARα upregulation, mRNA expression of 352 
enzymes involved in β-oxidation (Acad1, Acox1) were elevated in the liver of intermittent 353 
HFD-fed mice. Furthermore, fatty acylcarnitine accumulation was reduced in these mice. 354 
Of note, inherited fatty acid oxidation defects lead to an accumulation of fatty 355 
acylcarnitines in respect to the underlying mutation (52). In addition, treating HepG2 cells 356 
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in vitro with inhibitors of β-oxidation results in fatty acylcarnitine accumulation (20). All 357 
these findings therefore suggest a higher degree of β-oxidation in intermittent HFD-fed 358 
mice.  359 
Previous studies have shown that intermittent fasting over a longer time period 360 
restores fluctuations in fuel utilization and thereby metabolic flexibility (4, 5, 44). Herein 361 
we report that already a short bout of HFD for only four days impaired fasting-induced 362 
RER decline, which was maintained in intermittent HFD-fed mice. A quick adaptation to 363 
changing metabolic demands is the substantial characteristic of metabolic flexibility. 364 
During fasting, metabolism switches from a predominantly glucose to a predominantly 365 
lipid-based oxidation (19, 20). Our findings herein would suggest that intermittent HFD-366 
fed mice retained a higher degree of metabolic flexibility than ad libitum fed mice: they 367 
activated lipolysis in white adipose tissue more efficiently to supply FFA in order to meet 368 
peripheral energy requirements. In accordance with such notion, intermittent HFD-fed 369 
mice lost significantly more weight during fasting and gained significantly more weight 370 
during feeding.  371 
Of note, data in metabolic cages were only recorded during the last 24-hour period 372 
of the four-day feeding regimen. While such approach was chosen to allow group-housing 373 
of mice during the first three days, recording of metabolic cage data over a longer time 374 
period may be beneficial. Moreover, only male mice were included in the present study. It 375 
cannot be ruled out that female mice might have behaved differently. While we observed 376 
positive effects of short-term intermittent HFD-feeding on metabolism right after finishing 377 
the feeding regimen, we cannot speculate on how long such benefits may be maintained. 378 
Lipolysis was not assessed by the gold-standard isotope methodology but rather in 379 
isolated adipocytes ex vivo, which may not always be translated to in vivo conditions. 380 
18 
 
In conclusion, a short bout of HFD desynchronizes feeding behavior and impairs 381 
metabolic flexibility, which is prevented by retaining a normal feeding pattern. 382 
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Figure Legends 590 
 591 
Fig. 1 Ad libitum HFD feeding desynchronizes food intake immediately 592 
(A) Food intake was monitored in metabolic cages during the first day after introduction of 593 
HFD (n=5) and compared to chow-fed littermates (n=4). (B, C) Absolute and proportional 594 
food intake as well as changes in RER (D, E) during active/dark and inactive/light phase 595 
(HFD n=5, chow diet n=4). Values are expressed as mean (A, D) or mean±SEM (B, C, E). 596 
*p<0.05, **p<0.01, ***p<0.001 (Student’s t-test (C) or two-way ANOVA (B, E)). 597 
 598 
Fig. 2 Four days of intermittent HFD-feeding imposes a physiological pattern of 599 
food intake and fuel utilization 600 
 (A) Study design for intermittent feeding experiment. (B) Mean cumulative food intake 601 
over four days in ad libitum and intermittent HFD-fed littermates (n=3 per group). Body 602 
weight before and after four days of HFD (C) and weight changes during active/dark and 603 
inactive/light phase over four days of HFD-feeding (D) in intermittent and ad libitum HFD-604 
fed mice (n=6 mice per group).  Food intake (E, F), RER (G, H) and VO2 (I) on the fourth 605 
day of the respective feeding-regimen (n=4 ad libitum fed mice, n=3 intermittent fed mice). 606 
Values are expressed as mean (E, G) or mean±SEM (B-D, F, H). #p=0.06, *p<0.05 (two-607 
way ANOVA). 608 
 609 
Fig. 3 Intermittent HFD-feeding enhances fat accumulation and fasting-induced 610 
lipolysis in white adipose tissue  611 
(A) Weight of white adipose tissue depots (n=6 mice per group) and (B) adipocyte 612 
perimeter (n=4 mice per group) of intermittent and ad libitum HFD-fed littermates after five 613 
26 
 
hours of fasting on the fourth day of the respective feeding-regimen. Scale bar represents 614 
100 μm. (C, D) Representative Western blots and quantification of respective protein 615 
levels in white adipose tissue. Protein levels were normalized to ad libitum fed littermates 616 
within the same cohort (n=4 mice per group). Basal FFA release from isolated epididymal 617 
(E) or inguinal (F) adipocytes harvested from intermittent (n=4 for epididymal and n=3 for 618 
inguinal adipocytes) and ad libitum HFD-fed mice (n=3). (G) Portal FFA levels in 619 
intermittent and ad libitum HFD-fed mice (n=6 ad libitum fed mice, n=5 intermittent fed 620 
mice). Values are expressed as mean±SEM. *p<0.05, **p<0.01 (Student’s t-test).  621 
 622 
Fig. 4 Intermittent HFD promotes hepatic lipid accumulation, lipogenesis and β-623 
oxidation 624 
(A) Liver weight of intermittent and ad libitum HFD-fed mice (n=6 mice per group). (B) 625 
Representative Western blot and quantification of PPARγ1 protein levels in liver. Protein 626 
levels were normalized to ad libitum fed littermates within the same cohort (n=4 mice per 627 
group). (C) Relative mRNA expression levels of respective genes (n=4 ad libitum fed mice, 628 
n=3 intermittent fed mice). Hepatic triglyceride content (D) as well as intensity levels of 629 
most abundant TG (E) and DG (F) are shown (n=4 mice per group). (G) Relative mRNA 630 
expression of key-enzymes involved in β-oxidation (n=4 ad libitum fed mice, n=3 631 
intermittent fed mice). (H) Intensity levels of most abundant fatty acyl-carnitines are 632 
depicted (n=4 mice per group). (I) Relative mRNA expression levels of pro- and anti-633 
inflammatory cytokines in livers of ad libitum and intermittent HFD-fed mice (n=4 ad libitum 634 
fed mice, n=3 intermittent fed mice). Values are expressed as mean±SEM. #p<0.1 (E, F, 635 




Fig. 5 Intermittent HFD prevents HFD-induced impairment of glucose metabolism 638 
and metabolic flexibility  639 
(A) Intraperitoneal glucose tolerance test (ipGTT) before and after four days of ad libitum 640 
or intermittent HFD-feeding (n=9 mice per group). (B) Calculation of area under the curve 641 
(AUC) for ipGTT presented in Figure A. (C, D) RER during the first hour of fasting after 4 642 
days of respective HFD-regimen (n=4 ad libitum fed mice, n=3 intermittent fed mice). 643 
Values are expressed as mean±SEM. #p=0.06, *p<0.05, **p<0.01 (Student’s t-test (A, D) 644 
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